Wird geladen...
The p38 MAPK inhibitor BIRB796 enhances the antitumor effects of VX680 in cervical cancer
VX680 is a potent and selective inhibitor that targets the Aurora kinase family. The p38 mitogen-activated protein kinase (MAPK) regulates a large number of cellular pathways and plays an important role in the regulation of cell survival and apoptosis. This study aimed to evaluate the effect of VX68...
Gespeichert in:
| Veröffentlicht in: | Cancer Biol Ther |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Taylor & Francis
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4910916/ https://ncbi.nlm.nih.gov/pubmed/27082306 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2016.1177676 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|